Holen Sie sich die Stockscreener-App
0.228
7.35%
-0.0181
Handel nachbörslich:
.23
0.002
+0.88%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.2461
Offen:
$0.245
24-Stunden-Volumen:
4.75M
Relative Volume:
2.20
Marktkapitalisierung:
$21.41M
Einnahmen:
$36.12M
Nettoeinkommen (Verlust:
$-232.49M
KGV:
-0.0142
EPS:
-16.0015
Netto-Cashflow:
$-126.87M
1W Leistung:
-18.02%
1M Leistung:
-31.59%
6M Leistung:
-80.00%
1J Leistung:
-83.11%
1-Tages-Spanne:
$0.22
$0.2461
1-Wochen-Bereich:
$0.22
$0.2855
52-Wochen-Spanne:
$0.22
$2.27
Bionano Genomics Inc Stock (BNGO) Company Profile
Firmenname
Bionano Genomics Inc
Sektor
Telefon
(858) 888-7600
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Vergleichen Sie BNGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| BNGO | 0.228 | 21.41M | 36.12M | -232.49M | -126.87M | -16.00 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-12 | Fortgesetzt | BTIG Research | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-06-16 | Eingeleitet | BTIG Research | Buy |
| 2020-09-24 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-04-08 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Bionano Genomics Inc Aktie (BNGO) Neueste Nachrichten
Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) - MSN
Bionano Genomics Inc (BNGO) Quarterly 10-Q Report - Quartzy
Bionano Genomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $0.26 By Investing.com - Investing.com Australia
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... - Yahoo Finance
Optical Genome Mapping Market Size, Share, Trends, - openPR
Bionano Genomics Sees Growth in OGM Adoption - TipRanks
Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript - MSN
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Q3 Revenue Falls 35% Despite OGM System Growth; Reports Mixed Results | BNGO Stock News - StockTitan
Bionano Genomics stock hits 52-week low at $0.26 - Investing.com
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 - Barchart
Earnings Outlook For Bionano Genomics - Benzinga
U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.67% - Investing.com
Asia stocks fall as China stimulus disappoints, deflation persists - Investing.com
XRP Climbs 10.07% In Bullish Trade - Investing.com UK
Bionano Genomics Inc (BNGO): Major Improvements, Worth A Look - Stocks Register
Bionano Genomics (BNGO) Sets Q3 2024 Earnings Call for November 13 | BNGO Stock News - StockTitan
Optical Genome Mapping Market to Witness 26.76% CAGR During - GlobeNewswire
Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030Consumables and Reagents to Register High GrowthBionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - Yahoo Canada Finance
Bionano Genomics Announces $3 Million Registered Direct OfferingSAN DIEGO, Oct. 31, 2024 – Bionano Genomics, Inc. (Nasdaq: BNGO) recently finalized a definitive agreement with institutional investors for a registered direct offering. The of - Defense World
Bionano Genomics stock hits 52-week low at $0.27 By Investing.com - Investing.com Australia
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Genomics stock hits 52-week low at $0.27 - Investing.com India
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - The Manila Times
Waste Management (WM-N) QuotePress Release - The Globe and Mail
Bionano Genomics (STU:2Y30) Pre-Tax Income : €-189.69 Mil (TTM As of Jun. 2024) - GuruFocus.com
S&P 500 valuation suggests 1-2% price return over next decade: BofA - Investing.com
10 Best Penny Stocks to Invest in 2024 - Techopedia
Bionano Genomics' OGM outperforms in MYC gene study - Investing.com
Bionano Genomics' OGM outperforms in MYC gene study By Investing.com - Investing.com Canada
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma - StockTitan
Analysts Predict How High Bionano Genomics Inc (BNGO) Will Go. - Stocks Register
Bionano Genomics stock hits 52-week low at $0.3 amid market challenges - Investing.com
Taking on analysts’ expectations and winning: Bionano Genomics Inc (BNGO) - SETE News
BNGO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Bionano Genomics Inc (BNGO) deserves closer scrutiny - US Post News
Stock market today: S&P 500 closes above 5,800 for first time ever as banks rally - Investing.com
Bionano Genomics Inc [BNGO] Stock trading around $0.37 per share: What’s Next? - The DBT News
Bionano Genomics, Inc. Revises Revenue Guidance for the Third Quarter Ended September 30, 2024 - Marketscreener.com
Bionano Genomics Inc (BNGO) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Bionano Genomics reports lower Q3 revenue and cash reserves - Investing.com
Bionano Announces Preliminary 3Q 2024 Revenues and Cash - The Manila Times
Bionano Genomics reports lower Q3 revenue and cash reserves By Investing.com - Investing.com South Africa
Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Genomics Inc’s results are impressive - US Post News
Bionano Genomics Inc (BNGO)’s Market Momentum: Closing Strong at 0.46, Up 4.69 - The Dwinnex
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):